Brain Metastasis

Seven-year follow-up data of a multicenter, randomized phase 2 study evaluating the treatment of melanoma brain metastases shows ipilimumab plus nivolumab is an effective long-term care option.

A few years ago, UCLA organized a think tank between its neurosurgery and bioengineering departments.

J. Nicholas Bodor, MD, PhD, MPH, assistant professor in the department of hematology/oncology at Fox Chase Cancer, spoke with Healio about monitoring patients with recurrent EGFR-mutated lung cancer.

Amy Comander, MD, DipABLM, was not born a runner.

The addition of tucatinib to ado-trastuzumab emtansine significantly improved PFS among patients with unresectable locally advanced or metastatic HER2-positive breast cancer, according to study findings.

Healio spoke with Ahmed Elkhanany, MD, about where future research on metastatic triple-negative breast cancer should focus.

Patients with inflammatory breast cancer exhibited higher risk for central nervous system metastasis, according to study results published in Cancer.

In this video, Ravi Salgia, MD, PhD, highlighted two studies that investigated treatment for EGFR-mutated non-small cell lung cancer presented at ASCO Annual Meeting.

American Society for Radiation Oncology has issued a guideline on use of radiation therapy to treat patients with brain metastases.

ASCO, in collaboration with the Society for Neuro-Oncology and American Society for Radiation Oncology, has issued a guideline that emphasizes the significance of local therapies for patients with symptomatic brain metastases.